Inovio Pharmaceuticals, Inc. INO

1.18 (0.03) (2.48%) as of 25 Sep
Market cap
$126.9M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

— — — —
EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
0.79 1.40 1.04 1.00
Net Debt/EBITDA
2.49 3.49 1.78 2.05
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(0.41) (0.42) (0.31) (0.22)
Book value per Share
(0.15) 0.51 0.09 0.05
Free Cash Flow
(21.64) (19.50) (21.59) (18.05)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates